Remove industry pharma-competitive-intelligence
article thumbnail

Ready Players Win: Leaders of the Future Enterprise

CIO

To outpace these events, CIOs need to leverage resilience capabilities as a competitive advantage. It’s clear that more organisations are looking to establish a foundation for operational excellence, competitive differentiation, and long-term growth. On the contrary, spending on digital technology is set to grow by 3.5

Win 325
article thumbnail

Leaders That Reboot Their Game to Become a Future Enterprise

CIO

They use technology to stay competitive, shifting their priorities from just driving efficiency. This is where forward-thinking organisations will thrive by attracting digital talent, improving enterprise intelligence, scaling digital innovation, and more. Zuellig Pharma Holdings Pte.

Gaming 617
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Evolution of Pharma Market Research

Alpha Sense BI

The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. To capitalize on strategic growth, pharma organizations and investors need to stay up to date on the market-moving trends, shifts, and developments that are shaping the industry landscape.

article thumbnail

How CI Can Help Pharma Companies With the FDA Drug Approval Process

ArchIntel

“Global pharmaceutical manufacturing industry will reach $673.6 Competitive intelligence can help pharmaceutical companies secure drug approval from the Food and Drug Administration, according to Cipher President Peter Grimm. ArchIntel™ -. billion by 2027, growing by 12.5%

article thumbnail

7 Keys to Drug Launch Success

Netbasequid

The pharmaceutical industry is undergoing a transformation in the way new drugs are introduced into the market. Before the industry gets it right, we will see many failed drug launches. It’s important to take note of the intensifying competition in the industry. Here’s how to make sure it’s not yours!

article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Morgan’s Annual Healthcare Conference is the industry’s largest, most informative healthcare investment symposium. Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. In 2021, Spinraza sales reached $1.9

Biotech 96
article thumbnail

Know where your competitors are conducting clinical trials!

Sedulo

Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs. 2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma.

Biotech 52